Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 48 min ago
Peer-reviewedCC BYFrontiers in Immunology

Genetic and autoimmune predispositions to fulminant viral hepatitis in children

Abstract

Fulminant viral hepatitis (FVH) in children is a rare but often fatal form of acute liver failure occurring in the absence of preexisting liver disease. Its exceptional incidence during otherwise common viral infections, including hepatitis A virus (HAV), hepatitis B virus (HBV), and herpes simplex virus (HSV), supports a decisive role for host susceptibility. Recent advances in human immunogenetics delineate two major, mechanistically distinct pathways to pediatric FVH. The first reflects failure of immune regulation, culminating in excessive IFN-γ-driven inflammation and immune-mediated hepatocellular necrosis. Autosomal recessive IL-18BP and IL-10RB deficiencies exemplify this mechanism, in which disruption of key regulatory checkpoints permits uncontrolled activation of cytotoxic lymphocytes and macrophage-dependent immunopathology, particularly in the context of HAV infection. The second pathway involves impaired intrinsic antiviral defense, most prominently through neutralizing autoantibodies against type I interferons, which phenocopy genetic defects of IFN-I signaling and are strongly associated with HSV-triggered FVH; in this setting, inadequate early antiviral control enables unchecked hepatic replication with extensive cytopathic damage. Finally, syndromic hyperinflammatory disorders, including familial hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease, broaden the spectrum of immune predisposition in which fulminant hepatitis may arise. Together, these discoveries redefine pediatric FVH as an immunopathological syndrome and provide a framework for targeted genetic and serologic diagnosis and for mechanism-based interventions aimed at improving survival.

Related

  1. Veillonella dispar triggers dual-hits in the pathogenesis of autoimmune hepatitis and primary biliary cholangitis via testosterone depletion-BAFF-B cell axis and Th17 cell activation
    Y.-L. Liu, Q.-Q. Xing, X. Lin +9
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  2. Antigen specificity and inflammatory amplification in autoimmune hepatitis
    Zihao Xu, Yifan Liu, Haoyang Zou +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMCPMCEurope PMC
  3. Case Report: Acute liver failure in systemic lupus erythematosus with autoimmune hepatitis–primary biliary cholangitis overlap: a belimumab-containing regimen and longitudinal follow-up
    Lina Zhang, Tong Zhang, Jing Zhang +3
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMC
  4. Macrophage-derived IL-27 sustains autoreactive CD8+ cytotoxic T cells in autoimmune hepatitis
    K. Hao, S. G. Baptista, A. S. V. Beaumond +9
    bioRxivPreprintCC BYFull textImmunologybioRxiv
  5. Assessing the relationship between chronic aflatoxin exposure and hepatitis B virus immune protection in a population of children receiving nutritional support in Rwanda
    M. A. Matabishi, E. De Rycke, A. Chen +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textPlant biologyCrossref
BibTeX
@article{bousfiha2026genetic,
  title = {{Genetic and autoimmune predispositions to fulminant viral hepatitis in children}},
  author = {Mohamed Bousfiha and Dalal Ben Sabbahia and Emmanuelle Jouanguy and Jean-Laurent Casanova and Jalila El Bakkouri and Ahmed Aziz Bousfiha and Naima Amenzoui},
  journal = {Frontiers in Immunology},
  year = {2026},
  month = aug,
  doi = {10.3389/fimmu.2026.1858895},
  url = {https://hal.science/hal-05863784v1},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Genetic and autoimmune predispositions to fulminant viral hepatitis in children
AU  - Mohamed Bousfiha
AU  - Dalal Ben Sabbahia
AU  - Emmanuelle Jouanguy
AU  - Jean-Laurent Casanova
AU  - Jalila El Bakkouri
AU  - Ahmed Aziz Bousfiha
AU  - Naima Amenzoui
PY  - 2026
DA  - 2026/08/07
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1858895
UR  - https://hal.science/hal-05863784v1
AB  - Fulminant viral hepatitis (FVH) in children is a rare but often fatal form of acute liver failure occurring in the absence of preexisting liver disease. Its exceptional incidence during otherwise common viral infections, including hepatitis A virus (HAV), hepatitis B virus (HBV), and herpes simplex virus (HSV), supports a decisive role for host susceptibility. Recent advances in human immunogenetics delineate two major, mechanistically distinct pathways to pediatric FVH. The first reflects failure of immune regulation, culminating in excessive IFN-γ-driven inflammation and immune-mediated hepatocellular necrosis. Autosomal recessive IL-18BP and IL-10RB deficiencies exemplify this mechanism, in which disruption of key regulatory checkpoints permits uncontrolled activation of cytotoxic lymphocytes and macrophage-dependent immunopathology, particularly in the context of HAV infection. The second pathway involves impaired intrinsic antiviral defense, most prominently through neutralizing autoantibodies against type I interferons, which phenocopy genetic defects of IFN-I signaling and are strongly associated with HSV-triggered FVH; in this setting, inadequate early antiviral control enables unchecked hepatic replication with extensive cytopathic damage. Finally, syndromic hyperinflammatory disorders, including familial hemophagocytic lymphohistiocytosis and X-linked lymphoproliferative disease, broaden the spectrum of immune predisposition in which fulminant hepatitis may arise. Together, these discoveries redefine pediatric FVH as an immunopathological syndrome and provide a framework for targeted genetic and serologic diagnosis and for mechanism-based interventions aimed at improving survival.
SN  - 1664-3224
SN  - 1664-3224
ER  -